image
Healthcare - Biotechnology - NASDAQ - US
$ 1.985
5.59 %
$ 561 M
Market Cap
-2.51
P/E
BALANCE SHEET
395 M ASSETS
-23.23%
78.6 M LIABILITIES
-23.72%
317 M EQUITY
165.84%
BALANCE SHEET DECOMPOSITION
Balance Sheet Erasca, Inc.
image
Current Assets 321 M
Cash & Short-Term Investments 312 M
Receivables 0
Other Current Assets 8.33 M
Non-Current Assets 74.6 M
Long-Term Investments 10 M
PP&E 60.2 M
Other Non-Current Assets 4.38 M
Current Liabilities 26.2 M
Accounts Payable 2 M
Short-Term Debt 3.97 M
Other Current Liabilities 20.2 M
Non-Current Liabilities 52.5 M
Long-Term Debt 51.9 M
Other Non-Current Liabilities 566 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 93.1 284.2 360.5 65.4 29.6
Short Term Investments 219.3 151.4 54.0 53.3 20.8
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 8.3 8.9 11.1 2.6 1.5
Total Current Assets 320.7 444.5 420.0 120.0 51.1
PP&E 60.2 65.2 33.3 4.1 4.3
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 10.1 0.4 44.8 0.3 0
Other Long Term Assets 4.4 4.8 3.3 0.5 56 K
Other Assets 0 0 0 0 0
Total Assets 395.3 514.9 501.4 124.8 55.5
LIABILITIES
Accounts Payable 2.0 23.0 4.7 0.9 1.4
Short Term Debt 4.0 2.6 0.6 0.9 0.7
Other Current Liabilities 20.2 23.0 21.1 11.9 0.6
Total Current Liabilities 26.2 48.7 26.4 13.7 2.8
Long Term Debt 51.9 107.6 37.0 2.1 3.0
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0.6 (53.2) (18.5) 223.0 63.4
Total Liabilities 78.6 103.1 44.9 238.8 69.1
EQUITY
Common Stock 15 K 15 K 12 K 3 K 3 K
Retained Earnings (606.0) (481.0) (238.2) (115.4) (13.7)
Other Accumulative Comprehensive Income/Loss 77 K (1.0) (0.2) 2 K 11 K
Total Equity 316.7 (481.0) (238.2) (114.0) (13.6)
Total Liabilities and Equity 395.3 (377.9) (193.3) 124.8 55.5
SHARES OUTSTANDING
Common Shares Outstanding 150.2 122.0 119.1 119.0 119.0